|
Day 1
I. Drug Discovery for Enzyme Targets Chairs: Andreas Sewing & Niall Martin Speakers: Sir Philip Cohen University of Dundee; Ulf Boemer, Bayer; Nicola Curtin, CRUK; Spencer Campbell, Arrow Therapeutics; Stephan Heyse, Genedata; Namir Hassan, GlaxoSmithKline
II. Compound Management Diversifying the Corporate Collection Chairs: Stephen Garland, Jeff Paslay Speakers: Justin Bryans, MRCT; Zoe Blaxill, GlaxoSmithKline; Nunzio Sciammetta, Pfizer; Paul Leeson, AstraZeneca; Ijen Chen, Vernalis; Steve Garland, GlaxoSmithKline; Jeff Paslay, Wyeth
III. The Hard Cell: Current Issues in Drug Discovery & Screening Chairs: Richard Eglen & Martin Coldwell Speakers: Mark Thiede, Pfizer; Kathy Dodgson, AstraZeneca; Steve Rees, GlaxoSmithKline; Stefan Prectl, Bayer, Magalie Rocheville, GlaxoSmithKline, Dan Leggate, Cellzome, Julie Frearson, University of Dundee
Day 2
IV. Liquid Handling and Detection Technologies Chairs: Eric Tang, & John Comley Speakers: Rochdi Bouhelal, Novartis; Sabrinna Corazza, Axxam; Kevin Lowitz, Invitrogen; Eric Tang, AstraZeneca; Florian Hollfelder, Cambs University; Daniel Rines, GNF; Paula Harrison, Medlmmure
V. Biopharmaceutical Drug Discovery Chairs: Sandra Turconi & Richard Pither Speakers: Robert Karlsson, GE Healthcare; Alistair Lawson, UCB, Matthew Baker, Antilope, Rosemary Sasse, GlaxoSmithKline, Trevor Wattam, GlaxoSmithKline, Joost Kolkman, Ablynx
VI. Drug Discovery for GPCR Targets Chairs: Stephen Hill & Fiona Marshall Speakers: Annette Gilchrist, Caden Bio, Fiona Marshall, Heptares Therapeutic, Stefano Moro, University of Padova, Gebhard Schertler, Cambridge University, Martyn Wood, GlaxoSmithKline, Carrie Jones, Vanderbilt University
|